AN ACT RELATING TO INSURANCE -- BENEFIT DETERMINATION AND UTILIZATION REVIEW ACT

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 1 History 3 Sponsors 6

Prohibits healthcare insurers from requiring or conducting a review for prescription medicine used to treat alcohol or opioid use disorder containing Methadone, Burenorphine, or Naltrexone, or approved to mitigate opioid withdrawal symptoms.

Chamber: House
Introduced: Jan 21, 2026
Last action: Feb 3, 2026 — 02/03/2026 Committee recommended measure be held for further study
Sponsor: Julie Casimiro D
Session: 2026
Momentum: 5 · Stalled